851220-85-4 Usage
Quinolinone core
The compound has a quinolinone core, which is a chemical structure consisting of a bicyclic aromatic ring system with a carbonyl group attached to it.
Piperazinyl group
The compound contains a piperazinyl group, which is a heterocyclic ring structure composed of five members with two nitrogen atoms.
Chlorine atoms
The compound has two chlorine atoms attached to the phenyl ring, which can affect its chemical properties and biological activity.
Butoxy group
The compound has a butoxy group, which is a four-carbon alkyl chain attached to an ether oxygen atom.
Monohydrate form
The compound is in the form of a monohydrate, meaning it contains one molecule of water.
Pharmaceutical applications
The compound has potential applications in pharmaceuticals, as quinolinone derivatives have been found to exhibit various biological activities, including antimicrobial, antiviral, and anti-inflammatory properties.
Psychotropic activity
The presence of the piperazinyl group suggests possible activity as a psychotropic agent.
Research and development potential
The compound represents a promising area for further research and potential development in the fields of medicine and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 851220-85-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,1,2,2 and 0 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 851220-85:
(8*8)+(7*5)+(6*1)+(5*2)+(4*2)+(3*0)+(2*8)+(1*5)=144
144 % 10 = 4
So 851220-85-4 is a valid CAS Registry Number.
851220-85-4Relevant academic research and scientific papers
CRYSTALLINE ARIPIPRAZOLE SOLVATES
-
Page/Page column 22, (2008/06/13)
Alcoholates of aripiprazole are useful as pharmaceuticals and/or as intermediates in making aripiprazole Form A or Form B.
PROCESS FOR MAKING STERILE ARIPIPRAZOLE OF DESIRED MEAN PARTICLE SIZE
-
Page/Page column 7; 14, (2008/06/13)
A process is provided for making sterile aripiprazole having an average particle size less than 100 microns but preferably greater than 25 microns employing an impinging jet crystallization procedure. The resulting bulk aripiprazole of desired particle si
Process for making aripiprazole particles
-
Page/Page column 4-9, (2008/06/13)
A method of preparation of crystalline aripiprazole monohydrate includes the use of solution enhanced dispersion by supercritical fluid. Specifically, water is introduced to a stream of supercritical fluid which is then allowed to mix with a stream includ
